Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Acquisitions (2016 - 2024)

Historic Acquisitions for Angiodynamics (ANGO) over the last 11 years, with Q1 2024 value amounting to $3.2 million.

  • Angiodynamics' Acquisitions changed N/A to $3.2 million in Q1 2024 from the same period last year, while for Feb 2024 it was $3.8 million, marking a year-over-year increase of 60185.19%. This contributed to the annual value of -$4.2 million for FY2014, which is N/A changed from last year.
  • Angiodynamics' Acquisitions amounted to $3.2 million in Q1 2024.
  • In the past 5 years, Angiodynamics' Acquisitions ranged from a high of $10.0 million in Q1 2020 and a low of $540000.0 during Q4 2022
  • Moreover, its 4-year median value for Acquisitions was $3.4 million (2021), whereas its average is $4.3 million.